Northern Trust Corp Standard Biotools Inc. Transaction History

Northern Trust Corp

  • $690 Billion
  • Q4 2024

A detailed history of Northern Trust Corp transactions in Standard Biotools Inc. stock. As of the latest transaction made, Northern Trust Corp holds 2,875,160 shares of LAB stock, worth $3.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,875,160
Previous 2,631,638 9.25%
Holding current value
$3.22 Million
Previous $5.08 Million 0.95%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$1.5 - $2.26 $365,283 - $550,359
243,522 Added 9.25%
2,875,160 $5.03 Million
Q3 2024

Nov 13, 2024
BUY
$1.42 - $2.35 $2.31 Million - $3.83 Million
1,629,261 Added 162.54%
2,631,638 $5.08 Million
Q2 2024

Aug 14, 2024
BUY
$1.65 - $2.92 $358,790 - $634,951
217,449 Added 27.7%
1,002,377 $1.77 Million
Q1 2024

May 14, 2024
BUY
$1.87 - $2.78 $1.09 Million - $1.62 Million
583,830 Added 290.32%
784,928 $2.13 Million
Q4 2023

Feb 13, 2024
SELL
$1.59 - $2.73 $1,826 - $3,136
-1,149 Reduced 0.57%
201,098 $444,000
Q3 2023

Nov 13, 2023
BUY
$1.9 - $3.05 $52,181 - $83,765
27,464 Added 15.71%
202,247 $586,000
Q2 2023

Aug 11, 2023
BUY
$1.47 - $2.56 $1,299 - $2,263
884 Added 0.51%
174,783 $337,000
Q1 2023

May 15, 2023
BUY
$1.3 - $2.24 $4,102 - $7,069
3,156 Added 1.85%
173,899 $339,000
Q4 2022

Feb 13, 2023
SELL
$0.93 - $1.52 $888 - $1,451
-955 Reduced 0.56%
170,743 $199,000
Q3 2022

Nov 14, 2022
BUY
$1.1 - $2.06 $2,042 - $3,825
1,857 Added 1.09%
171,698 $188,000
Q2 2022

Aug 12, 2022
SELL
$1.6 - $3.99 $899,953 - $2.24 Million
-562,471 Reduced 76.81%
169,841 $273,000
Q1 2022

May 13, 2022
SELL
$2.8 - $3.96 $112,187 - $158,665
-40,067 Reduced 5.19%
732,312 $2.63 Million
Q4 2021

Feb 08, 2022
BUY
$3.63 - $6.13 $56,740 - $95,818
15,631 Added 2.07%
772,379 $3.03 Million
Q3 2021

Nov 15, 2021
SELL
$5.5 - $7.41 $104,098 - $140,249
-18,927 Reduced 2.44%
756,748 $4.99 Million
Q2 2021

Aug 13, 2021
SELL
$4.35 - $6.35 $107,018 - $156,222
-24,602 Reduced 3.07%
775,675 $4.78 Million
Q1 2021

May 12, 2021
SELL
$3.94 - $7.09 $269,184 - $484,395
-68,321 Reduced 7.87%
800,277 $3.62 Million
Q4 2020

Feb 11, 2021
BUY
$5.45 - $8.65 $26,966 - $42,800
4,948 Added 0.57%
868,598 $5.21 Million
Q3 2020

Nov 16, 2020
SELL
$4.34 - $11.43 $139,274 - $366,800
-32,091 Reduced 3.58%
863,650 $6.42 Million
Q2 2020

Aug 14, 2020
SELL
$1.85 - $5.29 $29,337 - $83,888
-15,858 Reduced 1.74%
895,741 $3.59 Million
Q1 2020

May 14, 2020
BUY
$1.24 - $4.35 $1,640 - $5,755
1,323 Added 0.15%
911,599 $2.32 Million
Q4 2019

Feb 14, 2020
SELL
$2.3 - $5.12 $49,985 - $111,272
-21,733 Reduced 2.33%
910,276 $3.17 Million
Q3 2019

Nov 13, 2019
BUY
$4.63 - $12.15 $1.83 Million - $4.8 Million
395,067 Added 73.58%
932,009 $4.32 Million
Q2 2019

Aug 13, 2019
BUY
$11.49 - $14.17 $534,055 - $658,621
46,480 Added 9.48%
536,942 $6.62 Million
Q1 2019

May 13, 2019
BUY
$8.47 - $14.36 $803,167 - $1.36 Million
94,825 Added 23.97%
490,462 $6.52 Million
Q4 2018

Feb 12, 2019
SELL
$7.18 - $8.83 $74,054 - $91,072
-10,314 Reduced 2.54%
395,637 $3.41 Million
Q3 2018

Nov 14, 2018
BUY
$5.92 - $8.35 $251,706 - $355,025
42,518 Added 11.7%
405,951 $3.04 Million
Q2 2018

Sep 18, 2018
SELL
$4.86 - $6.24 $11,785 - $15,132
-2,425 Reduced 0.66%
363,433 $2.17 Million
Q2 2018

Aug 14, 2018
SELL
$4.86 - $6.24 $501,697 - $644,155
-103,230 Reduced 22.01%
365,858 $2.18 Million
Q1 2018

May 09, 2018
BUY
$5.75 - $7.97 $14,150 - $19,614
2,461 Added 0.53%
469,088 $2.74 Million
Q4 2017

Feb 14, 2018
BUY
$4.46 - $6.45 $249,947 - $361,470
56,042 Added 13.65%
466,627 $2.75 Million
Q3 2017

Nov 13, 2017
BUY
$3.55 - $5.49 $1.46 Million - $2.25 Million
410,585
410,585 $2.07 Million

Others Institutions Holding LAB

# of Institutions
144
Shares Held
274M
Call Options Held
6.7K
Put Options Held
48.7K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $88.1M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email